Performance and Verification of a Real-Time PCR Assay Targeting the gyrA Gene for Prediction of Ciprofloxacin Resistance in Neisseria gonorrhoeae

ABSTRACT In the United States, 19.2% of Neisseria gonorrhoeae isolates are resistant to ciprofloxacin. We evaluated a real-time PCR assay to predict ciprofloxacin susceptibility using residual DNA from the Roche Cobas 4800 CT/NG assay. The results of the assay were 100% concordant with agar dilution susceptibility test results for 100 clinical isolates. Among 76 clinical urine and swab specimens positive for N. gonorrhoeae by the Cobas assay, 71% could be genotyped. The test took 1.5 h to perform, allowing the physician to receive results in time to make informed clinical decisions.

[1]  C. Schofield.  Sexually transmitted disease surveillance. , 1982, British medical journal.

[2]  G. Pugliese,et al.  Severe Streptococcus pyogenes Infections, United Kingdom, 2003–2004 , 2008, Emerging infectious diseases.

[3]  Thomas L. Madden,et al.  Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. , 1997, Nucleic acids research.

[4]  M. Ferraro.  Performance standards for antimicrobial susceptibility testing , 2001 .

[5]  G. Burstein,et al.  Sexually transmitted diseases treatment guidelines , 2003, Current opinion in pediatrics.

[6]  M. Siedner,et al.  Real-Time PCR Assay for Detection of Quinolone-Resistant Neisseria gonorrhoeae in Urine Samples , 2007, Journal of Clinical Microbiology.

[7]  K. Holmes,et al.  Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. , 2007, MMWR. Morbidity and mortality weekly report.

[8]  Vanessa G. Allen,et al.  Molecular Analysis of Antimicrobial Resistance Mechanisms in Neisseria gonorrhoeae Isolates from Ontario, Canada , 2010, Antimicrobial Agents and Chemotherapy.

[9]  M. Clementino,et al.  Molecular Characterization of Quinolone-Resistant Neisseria gonorrhoeae Isolates from Brazil , 2011, Journal of Clinical Microbiology.

[10]  D. Whiley,et al.  Protocol for the molecular detection of antibiotic resistance mechanisms in Neisseria gonorrhoeae. , 2012, Methods in molecular biology.

[11]  J. Papp,et al.  Update to CDC's Sexually transmitted diseases treatment guidelines, 2010: oral cephalosporins no longer a recommended treatment for gonococcal infections. , 2012, MMWR. Morbidity and mortality weekly report.

[12]  Monica Lahra,et al.  The ticking time bomb: escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting. , 2012, The Journal of antimicrobial chemotherapy.

[13]  D. Lewis,et al.  Determination of Neisseria gonorrhoeae susceptibility to ciprofloxacin in clinical specimens from men using a real-time PCR assay. , 2013, International journal of antimicrobial agents.

[14]  P. Kissinger,et al.  Chlamydia and gonorrhea screening in United States emergency departments. , 2013, The Journal of emergency medicine.

[15]  Cephalosporin resistance in Neisseria gonorrhoeae infections. , 2013, JAMA.

[16]  M. Unemo,et al.  Antimicrobial Resistance in Neisseria gonorrhoeae in the 21st Century: Past, Evolution, and Future , 2014, Clinical Microbiology Reviews.

[17]  Direct detection of markers associated with Neisseria gonorrhoeae antimicrobial resistance in New Zealand using residual DNA from the Cobas 4800 CT/NG NAAT assay , 2014, Sexually Transmitted Infections.

[18]  A. Endimiani,et al.  Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998–2012): emergence of multidrug-resistant clones less susceptible to cephalosporins , 2014, BMC Infectious Diseases.

[19]  M. Pandori,et al.  Neisseria gonorrhoeae Strain with Reduced Susceptibilities to Extended-Spectrum Cephalosporins , 2014, Emerging infectious diseases.

[20]  S. Solomon,et al.  Antibiotic resistance threats in the United States: stepping back from the brink. , 2014, American family physician.

[21]  K. Workowski,et al.  Sexually transmitted diseases treatment guidelines, 2015. , 2015, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[22]  M. Pandori,et al.  Fluoroquinolone Resistance in Neisseria gonorrhoeae After Cessation of Ciprofloxacin Usage in San Francisco: Using Molecular Typing to Investigate Strain Turnover , 2015, Sexually transmitted diseases.

[23]  W. Bower,et al.  Clinical Framework and Medical Countermeasure Use During an Anthrax Mass-Casualty Incident. , 2015, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[24]  G. Horsman,et al.  Molecular Assay for Detection of Genetic Markers Associated with Decreased Susceptibility to Cephalosporins in Neisseria gonorrhoeae , 2015, Journal of Clinical Microbiology.